Wednesday, October 8, 2025

The Case History (In Nine Circles)

In a small provincial kingdom — which, for diplomatic reasons, I shall call The Hospital of Virtum — there lived a lady of eighty-some years: intelligent, sharp-tongued, and weary of her own body. Her heart no longer kept time; her legs sang hymns of pain day and night.

A vascular surgeon, learned and distinguished, examined those legs as though they were chapters in an old, dog-eared book. He sighed and said,

“This requires a team the size of an orchestra.”

But the orchestra was on tour — indefinitely — so he prescribed two instruments instead: antibiotics and morphine.

The lady was of the old school.

“I’ve lived long enough to know what kills me,”
she said, shaking her head at the powders and elixirs of the modern age.

After much persuasion came antibiotics and probiotics, soups of virtue, kefir consultations — and yet the pain stayed. So the second remedy was tried: the opioid Hemamorphane, a word that might have escaped from Dante’s descent itself. Still, no relief. The legs burned as before.

By Sunday evening, the pain had become a symphony of torment. Her heart danced arrhythmically; her blood pressure soared like an opera soprano. At last, an ambulance was summoned — and arrived in the form of two very young angels in polyester uniforms, still fragrant with the smell of textbooks. They performed their EKG, boarded her ceremoniously, and whisked her away.

Inside, the air was infernal. The caregiver fumed; the patient moaned.
It was the Fifth Circle — wrath and despair, both boiling in the same cramped river.

They reached the Emergency Department, where time flows differently — slowly, cruelly. The nurse suggested more painkillers. The lady refused.

“I want to understand the cause,” she insisted. “Perhaps there are clots.”

The nurses exchanged a look.
Cause? In this kingdom, causes are mythical beasts — rarely seen, never captured.

So they rolled her into the waiting room, sat her in a wheelchair designed by medieval torturers, and left her under the flicker of fluorescent light. Around her gathered the other souls of Limbo: a girl with sepsis, her mask pale against the blue light of her phone; two teenagers scrolling through pain.

Then came the receptionist, guardian of the Second Circle.

“You must pay,” she said, “before any service.”

The caregiver paid. She was also given half a forest of forms to sign — unreadable, urgent, and perhaps binding her soul. She signed anyway. The lady’s face was white, her legs swollen like bread dough left too long in the sun.

Hours slipped by.

The chair was unkind. The lighting, penitential. After much pleading, an orderly adjusted her footrest by two centimeters - a gesture toward mercy, if not toward Paradise.

When she asked for a bathroom, both were locked — relics of a more civilized age.

And so they lingered — between the Third and Fourth Circles of our modern Inferno: Bureaucracy and Indifference.

And as the caregiver looked at the suffering patient, she thought: “If Dante were alive today, he would need a Triage Department for the damned.”

The caregiver’s patience cracked. She made a speech. The sepsis girl joined her in chorus, a duet of despair. At last, the guardians of this realm took pity - or offense - and moved them to separate waiting rooms. The new chair was softer and a bathroom available.

Progress.

Then came blood tests, then more waiting.
Morning brought results: D-dimer high. Suspicion of clots. An ultrasound was ordered. But there was a line — always a line.

“Don’t call us,” said the clerk. “We will call you.”

The caregiver called anyway. By midday, they were summoned back — through a labyrinth of nurses, numbers, and barcodes. Payment required, but cash and cards not accepted. The caregiver, bent over her phone, tapped through endless screens until at last a barcode appeared — salvation by QR code.

After two more offices and an hour of silence, their number flashed — then vanished.

“The team went on break,”
said the receptionist, tearing the ticket.
“You’ll need to take another number.”

At last, an ultrasound. The machine was ancient, its sound like bones grinding. The technician pressed hard — pain seared through the leg.

“No clots,” she announced.
“What about the other leg?”
“We only do one at a time,” came the reply.

Back to the nurse. More waiting. She smiled kindly but said,

“I can’t show you the results. I’d go to jail.”

Such is the law of Virtum.

Back to the ER. More forms, more indifference. Finally, a doctor — harried, hollow-eyed — arrived.

“Just take Tylenol,” he said.
Then, to the caregiver:
“Maybe it’s heart failure. What else do you want?”

And so they were discharged — the patient in more pain than when she entered, the caregiver in despair.

How long could she endure?
No one could say.


Epilogue

Let us note, for the record, that the illness of our time is not only in arteries or veins.
It is in the system itself — a moral arteriosclerosis that clogs compassion and chokes the flow of sense.

Around the world, the same symptoms appear.

In New York, twenty-year-old Sam Terblanche died after two visits to Mount Sinai Morningside. Diagnosed twice with “a viral syndrome,” he was sent home. Days later, he was found dead. The autopsy revealed pulmonary hemorrhage of unknown cause. Experts suspected sepsis, or a post-COVID autoimmune storm. None could say for sure. What’s certain is this: the system missed him.

In Winnipeg, Chad Christopher Giffin waited eight hours in the ER — and never made it out.
In Quebec, Adam Burgoyne, 39, was told he wasn’t “dying” — and left after six hours, only to die the next day.
In Italy, Cristina Pagliarulo perished after forty hours in a Pronto Soccorso.
In Ontario, sixteen-year-old Finlay van der Werken, bright and kind, died after an ER visit that should have saved him.

Different nations, same pathology.

The modern hospital has become a paradox — a place meant for healing that too often serves as a sorting center for the living and the nearly dead. The causes are known:

  1. Overstretched emergency rooms — overcrowded, understaffed, forced to “move the meat.”

  2. Diagnostic haste — rare, lethal cases lost amid the ordinary.

  3. Electronic record tyranny — notes for billing, not understanding.

  4. Fragmented accountability — no one person responsible, everyone “following protocol.”

  5. Cognitive bias — young and old alike dismissed because they don’t “look sick.”

  6. No continuity after discharge — once you leave, you vanish from the system.

  7. And towering above it all: administration - endless layers of approval, offices feeding offices, a machine designed to protect itself, not patients.


Transparency has evaporated — in places like Canada, you may not even be allowed to see your own test results. The system hides what it should reveal, and delays what it should decide.

Meanwhile, outside the hospital walls, people are already turning to tools that can do in minutes what bureaucracy and burnout stretch into weeks - AI systems that see patterns, synthesize, and recall what no overworked clinician has time to. 

The Hospital of Virtum is not a fantasy. It is everywhere - New York, Winnipeg, Milan, Montreal, Toronto.

The cure? Not another protocol. Not another app.

What’s needed is time, staff, accountability, and the permission to care.
A culture where asking why is not seen as defiance.
Where a locked bathroom is not a metaphor for the entire institution.

Until then, the triage line is the new Inferno —
and the dead keep teaching the living what compassion once meant.



REFERENCES

https://www.nytimes.com/2025/10/05/well/sam-terblanche-virus-death-columbia.html

https://archive.is/MgWJH#selection-693.288-693.375

https://news.ycombinator.com/item?id=45487519

https://www.winnipegfreepress.com/breakingnews/2025/01/24/probe-into-death-of-man-in-hsc-waiting-room-weeks-from-completion

https://www.ctvnews.ca/montreal/article/this-montreal-man-died-of-an-aneurysm-after-waiting-in-the-er-for-six-hours/

https://en.cronachedellacampania.it/2025/09/Pagliarulo-case%3A-Cristina%27s-autopsy-could-have-been-saved-if-operated-on-in-time/

https://globalnews.ca/news/11296590/ontario-family-sues-hospital-staff-sons-death/

Tuesday, August 12, 2025

Is the Future of Medicine Just a Prompt Away?

In Evaluating General-Purpose LLMs for Patient-Facing Use: Dermatology-Centered Systematic Review and Meta-Analysis (medRxiv, 2025), the data tells a fascinating story: large language models (LLMs) are improving in medical reasoning, empathy, and safety - but they’re not perfect, and trust takes time to earn. Which, come to think of it, sounds a lot like the long human history of hoping for miracle healers.

Long before stethoscopes, scalpels, and sterile gloves, our first “doctors” were magicians - or at least, that’s what everyone believed. Prehistoric healers waved bones, mumbled incantations, and applied sometimes questionable herbal pastes. Yet enough patients recovered to keep the legend alive.

Fast forward a few millennia and not much has changed… except the props. The bone rattle has been replaced by a diagnostic app. The “spirit-cleansing smoke” is now an MRI scan. And our new shamans? They’re called AI engineers.

Just like in the old days, we still crave the miracle cure, the instant fix, the all-knowing healer. Our dream is a tireless personal doctor who remembers every ache, every allergy, every bit of medical literature (plus the plot of every episode of Grey’s Anatomy).

When ChatGPT burst into the public spotlight in late 2022, some were fascinated and some were wary. Could a chatbot really diagnose a rash? Suggest a safe treatment? Explain it all in plain language?

Early studies, including those reviewed in the paper, painted a mixed picture. In 2022, the mood was skeptical. By 2023, optimism surged as newer models like GPT-4, Claude, and Gemini started showing measurable gains in accuracy, empathy, and communication. But by 2025, the mood had shifted again - not to cynicism, but toward a more critical view.

The truth is, AI in medicine is a lot like the magic of old: it works impressively well in certain contexts, but not always when or how you expect. LLMs are now better at interpreting images, offering solid medication safety advice, and even admitting when they don’t know - a kind of digital humility our ancestors probably wished their witch doctors had. But they still have limits. Even when an AI aces a medical board exam and offers great second opinions, patients using it alone don’t necessarily make better decisions.

That’s why the paper calls for evaluator-aware, patient-in-the-loop frameworks - ways of measuring not just whether the AI gets the right answer, but whether it helps real people make better choices. Because in healthcare, as in magic, the spell only works if it actually helps the patient in the real world.



REFERENCE

Irene S. Gabashvili Evaluating General-Purpose LLMs for Patient-Facing Use: Dermatology-Centered Systematic Review and Meta-Analysis medRxiv 2025.08.11.25333149; doi: https://doi.org/10.1101/2025.08.11.25333149

Friday, July 25, 2025

Catch-22 in Biomedicine: Where Innovation Goes to Die

Welcome to the biomedical field, where the real disease is the system, and the only approved cure is being part of the club.

Let’s start with a fun little circle, a biomedical version of a hamster wheel — Catch-22 with a white coat and a PubMed badge. Here’s how it works:  

  1. To Be Read, You Must Be Indexed.
    No matter how groundbreaking, disruptive, or life-saving your research is, it won’t exist in the eyes of the AI models and policymakers, unless it’s indexed in PubMed. That’s the velvet rope to the scientific VIP lounge.

  2. To Be Indexed, You Must Be Published in a Journal That’s... You Know, PubMed-Worthy.
    And to get into one of those? You need money. Either:

    • Pay the journal a small fortune (ranging from $2,000 to “you’re gonna need a second mortgage”), or

    • Be part of The Club™ - that elite group of insiders who don’t need to pay because they’ve been publishing in the same journals since Watson and Crick shared a sandwich.

  3. Oh, You Did Something Novel? Sorry, That’s Not on the Approved Menu.
    Maybe you developed a cost-saving, patient-driven clinical trial. Fantastic! But if it wasn’t:

    • Funded by Big Pharma, or

    • Backed by the NIH and conducted by a prestige university with ivy-covered walls,
      …then guess what? It doesn’t count. Reviewers will call it “methodologically unsound,” Editors will say "it's not interesting to our readers", which is code for “you didn’t buy the right ticket.”

  4. Citations: The Scientific Echo Chamber
    “You cite me, I cite you, we all cite the same five people we've known since grad school.”
    If your work isn’t already blessed by the existing canon, if it dares to question current paradigms, or (God forbid) it talks about a topic not discussed by the establishment, it’s tossed into the "Thanks but no thanks" pile.

    Citations are the currency of academia. But like real currency, they tend to trickle upward.


Exhibit A: The Case of PATM

Ever heard of People Are Allergic to Me (PATM)? No? Neither has most of PubMed, and certainly not your favorite dermatology AI (that will also tell you it's all in your head).

There was a peer-reviewed paper in JMIR Dermatology showing a microbial connection to PATM. It should’ve led to more interest in this condition. 
But alas, JMIR Derm isn’t indexed in PubMed - a technicality that renders the findings invisible (unless the work was funded by NIH). Not because they’re invalid. Just… you know… they weren’t invited to the club gala.

Now you might think, “But what about establishment research?” Surely that gets through, right?

Monell Center — a well-regarded sensory science institute — published a genetic study on TMAU, another condition ignored for decades. Even they faced an uphill battle. The research showed genetic heterogeneity, meaning the story isn’t as simple as the textbooks would like. Ten years to publish (DNA of 130 subjects that contacted Monnell in 1999 to 2007; the paper was published in 2017). Ten. Because journals prefer tidy answers like “it’s just gene X” over complex truths like “it’s complicated and we don't fully understand it yet.”


Meanwhile, In the Land of AI

Your health chatbot? Your AI diagnostic assistant? It only reads what’s been indexed. It’s like a well-read librarian who refuses to touch any book without a barcode.

Which means all those brilliant papers:

  • From underfunded startups,

  • Crowdfunded patient trials,

  • Off-mainstream yet rigorous researchers...

Are off the radar. So AI, policy, and public knowledge stay blissfully ignorant — not due to a lack of evidence, but a lack of access.


So Why Does This Matter?

Because if you're a poor patient, or a researcher without connections, or someone who just wants to challenge bad assumptions, the system isn't just hard - it's set up to make you invisible.

Innovation doesn't fail here because it’s wrong.
It fails because it wasn’t published in the right place, by the right people, citing the right authorities.


The Streetlight Effect in Science

We’re all looking for the cure under the scientific streetlight - not because it’s there, but because that’s where the funding, indexing, and citations shine.

Meanwhile, in the dark, the real solutions — weird, messy, complex, human solutions - are waiting. But who’s going to look there?

Nobody. Unless someone with the right credentials takes a flashlight.


REFERENCES

Gabashvili IS. Cutaneous bacteria in the gut microbiome as biomarkers of systemic malodor and People Are Allergic to Me (PATM) conditions: insights from a virtually conducted clinical trial. JMIR Dermatology. 2020 Nov 4;3(1):e10508. doi: 10.2196/10508

Guo Y, Hwang LD, Li J, Eades J, Yu CW, Mansfield C, Burdick-Will A, Chang X, Chen Y, Duke FF, Zhang J, Fakharzadeh S, Fennessey P, Keating BJ, Jiang H, Hakonarson H, Reed DR, Preti G. Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing. BMC Med Genet. 2017 Feb 15;18(1):11. doi: 10.1186/s12881-017-0369-8. PMID: 28196478; PMCID: PMC5310055.

blockquote { margin:1em 20px; background: #dfdfdf; padding: 8px 8px 8px 8px; font-style: italic; }